DUAC

This brand name is authorized in Estonia, Spain, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Malta, New Zealand, Poland, Romania, United Kingdom

Active ingredients

The drug DUAC contains a combination of these active pharmaceutical ingredients (APIs):

1 Clindamycin
UNII EH6D7113I8 - CLINDAMYCIN PHOSPHATE

Clindamycin is a lincosamide antibiotic with a primarily bacteriostatic action against Gram-positive aerobes and a wide range of anaerobic bacteria. Lincosamides such as clindamycin bind to the 50S subunit of the bacterial ribosome and inhibit the early stages of protein synthesis.

Read about Clindamycin
2 Benzoyl peroxide
UNII W9WZN9A0GM - BENZOYL PEROXIDE

Benzoyl peroxide is a highly lipophilic, oxidising agent with keratolytic and bacteriocidal effects. The effectiveness of benzoyl peroxide in the treatment of acne vulgaris is primarily attributable to its antibacterial activity, especially with respect to Propionibacterium acnes. Benzoyl peroxide is also believed to be effective in the treatment of acne on account of its anti-inflammatory and mild keratolytic properties.

Read about Benzoyl peroxide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
D10AF51 Clindamycin, combinations D Dermatologicals → D10 Anti-acne preparations → D10A Anti-acne preparations for topical use → D10AF Antiinfectives for treatment of acne
Discover more medicines within D10AF51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1155035, 1155046, 1155057, 1175723, 1175734, 1175947, 1175958, 1175969, 1539446
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 66679, 77733
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 225544, 298560, 301781, 301783, 376314, 381299
Country: HK Department of Health Drug Office Identifier(s): 62215
Country: IE Health Products Regulatory Authority Identifier(s): 22163, 22164, 36924
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 21016, 6589, 9119
Country: JP 医薬品医療機器総合機構 Identifier(s): 2699803Q1020
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1016652, 1016653, 1016654, 1021552, 1021553, 1021554, 1021555, 1021556, 1061759, 1064231, 1072993, 1072994, 1074504
Country: MT Medicines Authority Identifier(s): MA192/02801
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 11578
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100132247, 100305883, 100420064
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W67839001, W67839002

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.